<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03877575</url>
  </required_header>
  <id_info>
    <org_study_id>CRC_GHN_2019_003</org_study_id>
    <nct_id>NCT03877575</nct_id>
  </id_info>
  <brief_title>Lyon Uveitis Study</brief_title>
  <acronym>LYS</acronym>
  <official_title>Lyon Uveitis Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Uveitis or inflammation of the uveal tract results from a heterogeneous collection of
      disorders of varying etiologies and pathogenic mechanisms. Uveitis is relatively frequent in
      industrial countries with an estimation of 115 cases for 100 000 persons and is associated
      with a blindness risk of 10%. Causes of uveitis can be related to different etiologies
      (infectious, inflammatory or general inflammatory diseases). Therapeutic care is based on
      ophthalmologic and systemic diagnosis and treatment strategy depends on the severity of
      inflammation.

      The main objective of the Lyon uveitis study is to analyze the uveitis ophthalmologic
      etiology and diagnostic and therapeutic care of the patients. This study is proposed to all
      patients diagnosed for uveitis and referred to the Department of Internal Medicine of the
      Croix Rousse hospital, Lyon, france for etiologic diagnosis or treatment.

      Analysis of i) patients' characteristics, ii) the relevance of complementary exams to
      determine the uveitis etiology, iii) treatment used.

      This study will allow a better characterization of the disease on diagnosis practices and
      therapeutic care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical evolution (persistence or resolution) evaluated by gradation of SEN</measure>
    <time_frame>At one year after diagnosis</time_frame>
    <description>Persistence of disease is characterized by persistence of intraocular inflammation evaluated by gradation of SEN. (reference: A Standardization Grading System for Scleritis . Ophthalmology 2011 Apr;118(4):768-71). SEN score ranges from 0 to 5 (resolution = score 0 and persistence = score &gt;0)</description>
  </primary_outcome>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Uveitis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No specific intervention. Collection of clinical data</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study is proposed to all patients diagnosed for uveitis and referred to the Department
        of Internal Medicine of the Croix-Rousse hospital, Lyon, France for the first visit
        corresponding to etiologic diagnosis or treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of uveitis

          -  First consultation in the Department of Internal Medicine at the Croix-Rousse
             hospital, Lyon, France

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Pascal Sève, MD, PhD</last_name>
    <phone>+33-4 26 73 26 27</phone>
    <email>pascal.seve@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Internal Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Sève, MD, PhD</last_name>
      <phone>+33-4 26 73 26 27</phone>
      <email>pascal.seve@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 14, 2019</study_first_submitted>
  <study_first_submitted_qc>March 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>March 14, 2019</last_update_submitted>
  <last_update_submitted_qc>March 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

